Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Rolf A Klaasen"'
Autor:
Jakob Benedict Seidelin, Casper Steenholdt, Johan Burisch, Mohamed Attauabi, Nils Bolstad, David J Warren, Mads Damsgaard Wewer, Pernille Dige Ovesen, Johan F K F Ilvemark, Rolf A Klaasen
Publikováno v:
BMJ Open Gastroenterology, Vol 11, Iss 1 (2024)
Background and objective The influence of concomitant prednisolone on clinical outcomes and safety in infliximab-treated ulcerative colitis (UC) patients is unknown.Design, setting, participants and outcome measures A retrospective cohort study was p
Externí odkaz:
https://doaj.org/article/246dbc6cb8ed43ecb06ed52d03b9e22b
Autor:
Marthe Kirkesæther Brun, Kristin Hammersbøen Bjørlykke, Marte K. Viken, Grethe‐Elisabeth Stenvik, Rolf A. Klaasen, Johanna E. Gehin, David John Warren, Joseph Sexton, Øystein Sandanger, Tore K. Kvien, Cato Mørk, Espen A. Haavardsholm, Jørgen Jahnsen, Guro Løvik Goll, Benedicte A. Lie, Nils Bolstad, Kristin Kaasen Jørgensen, Silje Watterdal Syversen
Publikováno v:
Journal of Internal Medicine. 293:648-655
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f9d58cf2b9f8128b435cd3e7eb2a89
https://doi.org/10.1111/joim.13616
https://doi.org/10.1111/joim.13616
Autor:
Nils Tore Vethe, Marte Theie Gustavsen, Ida Robertsen, Karsten Midtvedt, Stein Bergan, Jean Debord, Jean-Baptiste Woillard, Anders Åsberg, Rolf Anton Klaasen
Publikováno v:
Clinical and Translational Science
Therapeutic drug monitoring (TDM) is mandatory for the immunosuppressive drug tacrolimus (Tac). For clinical applicability, TDM is performed using morning trough concentrations. With recent developments making tacrolimus concentration determination p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6b48c5df35d90d4038ebac81acf1fa
https://doi.org/10.1111/cts.12833
https://doi.org/10.1111/cts.12833
Autor:
Christine Berg Nordahl, Anders Mikal Andersen, Nils Tore Vethe, Kristine Hole, Rolf Anton Klaasen, Stein Bergan, Morten Skauby, Karsten Midtvedt, Sara Bremer
Publikováno v:
British Journal of Clinical Pharmacology
Aims To explore the pharmacodynamics of mycophenolic acid (MPA) through inosine monophosphate dehydrogenase (IMPDH) capacity measurement and purine levels in peripheral blood mononuclear cells (PBMC) longitudinally during the first year after renal t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22202ab40cd4898c45d8176a46bea2a
https://doi.org/10.1111/bcp.14218
https://doi.org/10.1111/bcp.14218
Autor:
Marthe Kirkesæther Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, Joseph Sexton, Johanna Elin Gehin, Øystein Sandanger, Inge Christoffer Olsen, Rolf Anton Klaasen, David John Warren, Cato Mørk, Tore K. Kvien, Jørgen Jahnsen, Nils Bolstad, Espen A. Haavardsholm, Silje Watterdal Syversen
Background Anti-drug antibodies (ADAb) frequently form early in the treatment course of infliximab and other tumour necrosis factor (TNF) inhibitors, leading to treatment failure and adverse events. Objective To identify risk factors for ADAb in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb29427a0b28cd39dfac2c5335335f12
http://hdl.handle.net/10852/97708
http://hdl.handle.net/10852/97708
Autor:
Rolf A. Klaasen, David J. Warren, Rasmus Iversen, Nils Bolstad, Ina L. Andersen, Patricia Mjønes, Elin Rønne, Knut E.A. Lundin, Ludvig M. Sollid, Eivind Ness–Jensen
Publikováno v:
Clinical Biochemistry
Background The aim of the present study was to develop and clinically validate a high-throughput assay for serum IgA and IgG antibodies against transglutaminase-2 (TG2) and to determine appropriate assay cut-offs for large-scale population screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eef814ad8e41ac6fbe8660b51ff74b9
https://hdl.handle.net/11250/3018382
https://hdl.handle.net/11250/3018382
Autor:
Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll, Marthe Kirkesæther Brun, Øystein Sandanger, Kristin Hammersbøen Bjørlykke, Joseph Sexton, Inge Christoffer Olsen, Johanna Elin Gehin, David John Warren, Rolf Anton Klaasen, Geir Noraberg, Trude Jannecke Bruun, Christian Kvikne Dotterud, Maud Kristine Aga Ljoså, Anne Julsrud Haugen, Rune Johan Njålla, Camilla Zettel, Carl Magnus Ystrøm, Yngvill Hovde Bragnes, Svanaug Skorpe, Turid Thune, Kathrine Aglen Seeberg, Brigitte Michelsen, Ingrid Marianne Blomgren, Eldri Kveine Strand, Pawel Mielnik, Roald Torp, Cato Mørk, Tore K. Kvien, Jørgen Jahnsen, Nils Bolstad, Espen A. Haavardsholm
Publikováno v:
JAMA
IMPORTANCE: Proactive therapeutic drug monitoring (TDM), consisting of individualized treatment based on scheduled assessments of serum drug levels, has been proposed as an alternative to standard therapy to optimize efficacy and safety of infliximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19e319169617671a2db100d68ab77ac
https://europepmc.org/articles/PMC8693274/
https://europepmc.org/articles/PMC8693274/
Autor:
E. K. Strand, I. S. H. Hatten, Kathrine A. Seeberg, Knut E.A. Lundin, Rolf Anton Klaasen, Tore K Kvien, Knut Tveit, C. Mørk, Espen A Haavardsholm, S. S. Hoie, G. L. Goll, Gert Huppertz-Hauss, Jon Hagfors, A. Poyan, Synøve Kalstad, B. Gulbrandsen, Geir Noraberg, Jørgen Jahnsen, David J. Warren, K. Waksvik, K. Ryggen, H. U. Rashid, Cecilia Vold, Ingrid Prytz Berset, Øivind Asak, Nils Bolstad, S. O. Frigstad, Bjørg Tilde Svanes Fevang, Bjørn Moum, Ulf Prestegård, Joseph Sexton, C. C. Zettel, I. P. Midtgard, Magne Henriksen, Ingrid M. Blomgren, M. Lorentzen, Roald Torp, Carl Magnus Ystrøm, K. Skjetne, T. J. Bruun, Katrine Dvergsnes, Pawel Mielnik, J. Krogh, Ø. Brenna, Inge C. Olsen, Inger Marie Jensen Hansen, S. Baigh, K. K. Jørgensen
Publikováno v:
Journal of Internal Medicine
BACKGROUND AND OBJECTIVES: The 52-week, randomized, double-blind, noninferiority, government-funded NOR-SWITCH trial demonstrated that switching from infliximab originator to less expensive biosimilar CT-P13 was not inferior to continued treatment wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2e54f175da6e1a1bd891ec3eb52816
https://doi.org/10.1111/joim.12880
https://doi.org/10.1111/joim.12880
Autor:
E.S. Norli, Rolf Anton Klaasen, Tore K Kvien, J. E. Gehin, M.D. Mjaavatten, G. L. Goll, Silje W Syversen, David J. Warren, Nils Bolstad, Trine Bjøro
Publikováno v:
Rheumatology International
The aim of the study was to assess RF cross-reactivity to animal antibodies used in immunoassays, and to test if selected commercial immunoassays are vulnerable to interference from RF, causing false test results. Our study included samples from pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbf3d2e43b7421df9cd75339b7d8d16
http://hdl.handle.net/10852/92568
http://hdl.handle.net/10852/92568
Autor:
Nils Bolstad, Svanaug Skorpe, Yngvill Hovde Bragnes, Øystein Sandanger, Anne Julsrud Haugen, Roald Torp, Lars Normann Karlsen, Silje W Syversen, G. L. Goll, Ingrid M. Blomgren, David J. Warren, Camilla Zettel, Inge C. Olsen, Turid Thune, Christian Kvikne Dotterud, Brigitte Michelsen, Jørgen Jahnsen, Rune Johan Njålla, Geir Noraberg, K. K. Jørgensen, Pawel Mielnik, Carl Magnus Ystrøm, Kathrine A. Seeberg, J. E. Gehin, Joseph O. Sexton, Tore K Kvien, C. Mørk, Maud Kristine Aga Ljoså, Rolf Anton Klaasen, Trude Jannecke Bruun, Marthe Kirkesæther Brun, Espen A Haavardsholm, E. K. Strand
Publikováno v:
Journal of the American Medical Association (JAMA)
Importance Proactive therapeutic drug monitoring (TDM), defined as individualized drug dosing based on scheduled monitoring of serum drug levels, has been proposed as an alternative to standard therapy to maximize efficacy and safety of infliximab an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7427e8aee61a86b9681517c460490d0
https://hdl.handle.net/11250/3048675
https://hdl.handle.net/11250/3048675